Corvus Pharmaceuticals, Inc. (CRVS) News
Follow Corvus Pharmaceuticals, Inc. (CRVS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Corvus Pharmaceuticals to participate in Cantor Global Healthcare conference
Corvus Pharmaceuticals said its leadership team will hold one-on-one investor meetings and take part in a fireside chat at the 2026 Cantor Global Healthcare Conference.
EQUITY | Sep 03, 2026, 12:37 PM UTC
L
Corvus Pharmaceuticals to present at 2026 Cantor Global Healthcare Conference
Corvus Pharmaceuticals (CRVS) plans to present at the 2026 Cantor Global Healthcare Conference.
EQUITY | Sep 03, 2026, 12:31 PM UTC
L
Corvus Pharmaceuticals to publish final Phase 1 data in Blood
Corvus Pharmaceuticals announced publication in Blood of final Phase 1 data from the Soquelitinib Phase 1/1b T cell lymphoma trial.
EQUITY | Aug 27, 2026, 11:37 AM UTC
L
Corvus Pharmaceuticals publishes final Phase 1 Soquelitinib data in Blood
Corvus Pharmaceuticals says final Phase 1 data from its Soquelitinib Phase 1/1b T cell lymphoma trial was published in Blood.
EQUITY | Aug 27, 2026, 11:30 AM UTC
L
CRVS - Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026
CRVS - Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026
EARNINGS | Jul 30, 2026, 08:01 PM UTC
L
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at on our options activity scanner. Traders often look for
EQUITY | Jul 01, 2026, 05:35 PM UTC